Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Genitourinary 1

Conditions

Prostatic Neoplasms 5Breast Neoplasms 4Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Overweight 2Obesity 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Smoking Cessation 1Quality of Life 1Postoperative Complications 1Patient Compliance 1Neoplasms 1Metabolic Syndrome 1Localized Prostate Carcinoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypothalamic Neoplasms 1Healthy Diet 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 137Nivolumab 116Ipilimumab 68Cyclophosphamide 33Specimen Handling 31Magnetic Resonance Spectroscopy 28trametinib 23binimetinib 22fludarabine 21Interleukin-2 20dabrafenib 19relatlimab 17encorafenib 17Biopsy 17CTLA-4 Antigen 16cemiplimab 15atezolizumab 15aldesleukin 15Radiosurgery 15fludarabine phosphate 14Opdualag 14Radiotherapy 11lenvatinib 10Blood Specimen Collection 10lifileucel 9Paclitaxel 8Cisplatin 8Bevacizumab 8spartalizumab 7cobimetinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Diet Therapy × 1 year × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT04645680 2026-01-30

DIET

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡